Table 2.
Risk stratification | Classification | HN (%) | Method 1 | Method 2 | Method 3 | WT |
---|---|---|---|---|---|---|
Epithelial | Intermediate | 0 | 80 | 83.3 | 85 | 16 |
Mixed | Intermediate | 40 | 3 | 2.3 | 41 | 27 |
Mixed | Intermediate | 65 | 10 | 10.0 | 5 | 21 |
Diffuse anaplasia | High | 35 | 65 | 56.7 | 70 | 24 |
Regressive | Intermediate | 85 | 2 | 1.7 | 94 | 6 |
Regressive | Intermediate | 90 | 60 | 56.7 | 58 | 7 |
Epithelial | Intermediate | 10 | 6 | 6.0 | 24 | 6 |
Mixed | Intermediate | 65 | 35 | 33.3 | 81 | 1 |
Stromal | Intermediate | 60 | 70 | 68.3 | 14 | 7 |
Regressive | Intermediate | 80 | 65 | 60.0 | 79 | 5 |
Focal anaplasia/mixed | Intermediate | 25 | 85 | 83.3 | 57 | 2 |
Regressive | Intermediate | 80 | 7.5 | 8.3 | 86 | 2 |
Blastemal | High | 0 | 5 | 7.3 | −13 | 5 |
Blastemal | High | 25 | 35 | 36.7 | 71 | 6 |
Diffuse anaplasia | High | 20 | - | - | 31 | 19 |
Stromal | Intermediate | 45 | - | - | 18 | 10 |
Regressive | Intermediate | 66 | - | - | 69 | 14 |
Mixed | Intermediate | 85 | - | - | 87 | 1 |
Mixed | Intermediate | 50 | - | - | 16 | 21 |
Mixed | Intermediate | 10 | - | - | 56 | 5 |
Necrotic | Low | 100 | - | - | 94 | 1 |
Mixed | Intermediate | 80 | - | - | 93 | 16 |
Regressive | Intermediate | 97 | - | - | 77 | 7 |
Epithelial | Intermediate | 0 | - | - | 42 | 20 |
Mixed | Intermediate | 0 | - | - | 6 | 25 |
Stromal | Intermediate | 10 | - | - | 26 | 12 |
Regressive | Intermediate | 80 | - | - | 32 | 17 |
Blastemal | High | 60 | - | - | 86 | 5 |
Stromal | Intermediate | 6 | - | - | 34 | 5 |
Regressive | Intermediate | 85 | - | - | 74 | 15 |
Necrotic | Low | 100 | - | - | 34 | 29 |
Necrotic | Low | 100 | - | - | 93 | 19 |
Regressive | Intermediate | 85 | - | - | 56 | 45 |
HN: Histological necrosis, WT: Waiting time between last imaging and surgical resection in days